Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.
Schultz, LM; Baggott, C; Prabhu, S; Pacenta, HL; Phillips, CL; Rossoff, J; Stefanski, HE; Talano, JA; Moskop, A; Margossian, SP; et al.
Journal of Clinical Oncology.
2022;
40:945-955.
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report.
Fabrizio, VA; Phillips, CL; Lane, A; Baggott, C; Prabhu, S; Egeler, E; Mavroukakis, S; Pacenta, H; Rossoff, J; Stefanski, HE; et al.
Blood Advances.
2022;
6:600-610.
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia.
Levine, JE; Grupp, SA; Pulsipher, MA; DIetz, AC; Rives, S; Myers, GD; August, KJ; Verneris, MR; Buechner, J; Laetsch, TW; et al.
Journal for ImmunoTherapy of Cancer.
2021;
9.
Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effective.
Rubinstein, JD; Shah, R; Breese, EH; Burns, KC; Mangino, JL; Norris, RE; Lee, L; Mizukawa, B; O'Brien, MM; Phillips, CL; et al.
Pediatric Blood and Cancer.
2021;
68.
Novel Treatment of Infant With COVID-19 With the Sialidase Fusion Protein, DAS181.
Danziger-Isakov, L; Khalil, N; Divanovic, A; Frenck, R; Grimley, M; Iliopoulos, I; Marsh, R; Paulsen, G; Phillips, CL; Schulert, G; et al.
Pediatric Infectious Disease Journal.
2021;
40:e234-e235.
Hyperdiploid Precursor B-acute Lymphoblastic Leukemia Presenting as a Cavernous Sinus Mass in a 4-Year-old Male.
Sabulski, A; Bartlett, AL; Koch, BL; Vatner, R; Mizukawa, B; Phillips, CL.
Journal of Pediatric Hematology/Oncology.
2021;
43:e494-e497.
Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia.
Breese, EH; Krupski, C; Nelson, AS; Perentesis, JP; Phillips, CL.
Journal of Pediatric Hematology/Oncology.
2021;
43:152-154.
Hyperdiploid Precursor B-acute Lymphoblastic Leukemia Presenting as a Cavernous Sinus Mass in a 4-Year-old Male.
Sabulski, A; Bartlett, AL; Koch, BL; Vatner, R; Mizukawa, B; Phillips, CL.
Journal of Pediatric Hematology/Oncology.
2021;
43:e494-e497.
149 Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion Following Loss of B-Cell Aplasia in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia: HESTER Phase II Study.
Boyer, MW; Chaudhury, S; Davis, KL; Driscoll, TA; Grupp, S; Hermiston, M; John, S; Keating, AK; Kovacs, C; Magley, A; et al.
Transplantation and cellular therapy.
2021;
27:s141-s142.
HESTER: A Phase II Study Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia Experiencing Loss of B-Cell Aplasia.
Boyer, MW; Chaudhury, S; Davis, KL; Driscoll, TA; Grupp, SA; Hermiston, M; John, S; Keating, AK; Kovacs, C; Magley, A; et al.
Blood.
2020;
136:23-24.